TCM Share Price Today | Stock Price & TCM Share Screener
As of October 5, 2026, the live TCM share price (BSE: TCMLMTD) is ₹47.00, down 2.08% from the previous close, with shares trading between ₹47.00 and ₹48.00 in today's trading session, and a 52-week range of ₹37.21–₹74.33. Check TCMLMTD 52-week chart for the annual price range and momentum. Use the TCM stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today TCM opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹5 and net income of ₹-2, with EBITDA of ₹-1, an operating margin of -24.0% and a profit margin of -40.0%.
TCM Share Price Chart
Track the current stock price of TCM with an interactive chart. Analyse TCMLMTD share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete TCM stock quote in one place.
The quote of ₹47.00 sits between the 52-week low of ₹37.21 and the 52-week high of ₹74.33, and the latest session moved -2.08% from the previous close.
TCM Company Profile - Fundamental Screener
Screen TCM company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TCMLMTD shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Commodity Chemicals industry, and it trades under ISIN INE034F01010.
Company Details
Classification
Identifiers and Leadership
TCM Balance Sheet Screener
Screen TCMLMTD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹83, up from ₹76 in 2025.
Latest statistics put total assets at ₹83 and shareholder funds at ₹23, with a leverage ratio of 0.60.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 83 | 76 | 84 | 69 | 61 | 68 | 65 | 69 |
| Current Assets | 44 | 42 | 46 | 10 | 5 | 6 | 5 | 9 |
| Fixed Assets | 16 | 14 | 17 | 36 | 55 | 59 | 58 | 58 |
Liabilities |
||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 9 | 0 | 20 | 20 | 20 | 20 | 20 | 20 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 23 | 29 | 28 | 30 | 24 | 33 | 33 | 32 |
| Share Capital | 8 | 8 | 8 | 8 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 17 | 23 | 21 | 23 | 22 | 29 | 29 | 29 |
TCM Income Statement Screener - Profit & Revenue Analysis
Screen TCM income statement and profit fundamentals. Analyze TCMLMTD quarterly results. TCM reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹5 and net profit was ₹-2, equal to earnings per unit of ₹-2.20, at an operating margin of -24%.
In that period expenses were ₹6, interest cost ₹1 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹5 and net profit of ₹-2.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 5 | 5 | 12 | 3 | 7 | 6 | 9 | 5 | 7 | 6 | 5 | 7 | 5 | 11 | 2 |
| Expenses | 6 | 6 | 8 | 5 | 7 | 6 | 9 | 6 | 8 | 7 | 6 | 8 | 7 | 11 | 6 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | -1 | -1 | 4 | -2 | 0 | -1 | 0 | -1 | -1 | -1 | -1 | -1 | -2 | 1 | -4 |
| Operating Profit % | -24.00% | -20.00% | 1.00% | -61.00% | -14.00% | -10.00% | -8.00% | -20.00% | -8.00% | -10.00% | -15.00% | -10.00% | -33.00% | 7.00% | -331.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -2 | -2 | 4 | -2 | -1 | -1 | 0 | -1 | -1 | -1 | -1 | -1 | -2 | 1 | -4 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -2 | -2 | 4 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | 1 | -4 |
| EPS | -2.20 | -2.14 | 5.39 | -3.00 | -1.05 | -1.53 | -0.48 | -1.31 | -0.77 | -1.16 | -1.35 | -0.89 | -2.21 | 0.98 | -11.76 |
TCM Cash Flow Screener - Liquidity Fundamentals
Screen TCMLMTD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹5.
Over the same period, investing activities used ₹4 and financing activities provided ₹9.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | -5 | -10 | 2 | -11 | -4 | 0 | -1 | -2 |
| Investing Activities | -4 | 0 | -1 | 6 | 4 | -1 | 0 | 0 |
Financing and Net Cash | ||||||||
| Financing Activities | 9 | 10 | -1 | 5 | 0 | 0 | -3 | 5 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -4 | 4 |
TCM Shareholding Pattern Screener
See TCM shareholding pattern with promoter, FII, and DII holdings. Check TCM promoter holding and ownership changes for TCMLMTD on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 49.51%, foreign institutions 0.00%, domestic institutions 7.44% and the public 38.35%, spread across 4,198 shareholders.
The shareholder count was 4,198 in 2026-Mar, compared with 4,160 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 49.51% | 49.51% | 49.51% | 49.51% | 49.51% | 49.51% | 49.51% | 49.51% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 7.44% | 7.44% | 7.44% | 7.44% | 7.44% | 7.44% | 7.71% | 7.44% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 38.35% | 38.98% | 38.80% | 38.77% | 38.79% | 38.39% | 36.91% | 38.57% |
| Other Holding | 4.70% | 4.07% | 4.25% | 4.28% | 4.26% | 4.66% | 5.87% | 4.48% |
| Shareholder Count | 4,198 | 4,160 | 4,590 | 4,513 | 4,564 | 4,272 | 3,972 | 3,991 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by TCM. TCM dividend yield can be compared with peers and other stocks in the market.
TCM Stock Index Membership - Nifty & Sensex
See which indices include TCM stock. Check TCMLMTD index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
TCM Market Events Screener - Corporate Actions
Get TCM corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check TCM stock events that may affect TCMLMTD share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 25, 2026, with a record date of September 25, 2026.
It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 26, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-25 | 2026-09-25 | Annual General Meeting | NA | 23.95% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -4.33% |
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | -2.70% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 2.25% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 18.24% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | 5.35% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | 1.66% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -0.05% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -3.67% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 3.11% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 7.39% |
| 2023-11-22 | 2023-11-22 | Extraordinary General Meeting | NA | -19.35% |
| 2023-09-29 | 2023-09-29 | Annual General Meeting | NA | -1.29% |
| 2022-07-29 | 2022-07-29 | Extraordinary General Meeting | NA | 15.39% |
| 2022-04-26 | 2022-04-27 | Rights | 6:5 | 21.40% |
TCM Competitors Screener - Peer Stocks Comparison
Screen TCMLMTD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Deepak Fertilisers & Petrochemicals | 16,422 | 17.33 | 11,609 | 12.11% | 739 | 39.27 |
| Tata Chemicals | 15,484 | -7.90 | 14,900 | -1.40% | -1,715 | 39.22 |
| Gujarat Narmada Valley Fert & Chem | 8,657 | 8.56 | 8,272 | -1.45% | 798 | 50.00 |
| TANFAC Industries | 7,051 | 104.37 | 713 | 27.42% | 70 | 45.84 |
| Gujarat Alkalies & Chemicals | 4,433 | 68.43 | 4,475 | 7.44% | -2 | 33.44 |
| Grauer & Weil | 3,709 | 23.44 | 1,240 | 5.07% | 164 | 56.64 |
| GHCL | 3,701 | 7.91 | 3,138 | -4.08% | 473 | 23.75 |
| Chemplast Sanmar | 3,029 | -7.55 | 4,252 | -3.21% | -280 | 55.53 |
| JG Chemicals | 2,392 | 31.99 | 973 | 13.40% | 70 | 50.90 |
| Fischer Medical Ventures | 2,190 | 95.71 | 321 | 186.01% | 31 | 40.39 |
TCM Company Announcements - News & Reports Screener
Screen TCMLMTD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 1, 2026.
The next most recent announcements are dated September 30, 2026 and September 27, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-01 | Closure of Trading Window | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-27 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-18 | Mou For Forming A Joint Venture For The Development Of A Premium Residential Villa Project At Kalamassery Ernakulam | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-02 | Intimation Under Regulation 30 Of The SEBI(LODR) Regulations 2015 For Poultry Feed Launch/Production | - |
| 2026-08-31 | Reg. 34 (1) Annual Report. | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Intimation For Book Closure For The Purpose Of 82Nd Annual General Meeting For The Company To Be Held On Friday 29Th September 2026 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2026 And Consolidated And Standalone Financial Results And Limited Review Reports For Quarter Ended 30Th June 2026 | - |
| 2026-07-30 | Board Meeting Intimation for The Consideration And Approval Of Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026 | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-26 | Board Meeting Outcome for Outcome Of Board Meeting Held On 26Th May 2026 And Audited Consolidated And Standalone Financial Results For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-20 | Board Meeting Intimation for Consideration And Approval Of The Consolidated And Standalone Audited Financial Statements For The Quarter And Year Ended 31St March 2026 | - |
| 2026-04-30 | Corporate Update-Cancellation Of Order | - |
| 2026-04-22 | Disclosure/Declaration Under Regulation 31(4) Of SEBI(SAST) Regulations 2011 For The FY Ended 31St March 2026 From The Promoters Of The Company | - |
| 2026-04-22 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹47.00, within a 52-week range of ₹37.21 to ₹74.33. The P/E ratio is -7.15 and the P/B ratio is 1.51, with earnings per unit of ₹-7.78. Market capitalisation stands at ₹35.89 Cr. The company operates in the Chemicals sector, in the Commodity Chemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.